Publications


Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis: Results from a cross-sectional study.
Medicine (Baltimore) 2017 Aug;96(34):e7896
aDivision of Rheumatology, Department of Biotechnological and Applied Clinical Science, University of L'Aquila, L'Aquila bDepartment of Health Sciences, University of Catanzaro "Magna Graecia", Catanzaro cDivision of Rheumatology, Department of Internal Medicine, University of Palermo, Palermo, Italy.


Interstitial lung disease in systemic sclerosis: current and future treatment.
Rheumatol Int 2017 Jun 6;37(6):853-863. Epub 2017 Jan 6.
Department of Biotechnological and Applied Clinical Science, Rheumatology Unit, School of Medicine, University of L'Aquila, Delta 6 Building, Via dell'Ospedale, 67100, L'Aquila, Italy.



Ectopic expression of CXCL13, BAFF, APRIL and LT-β is associated with artery tertiary lymphoid organs in giant cell arteritis.
Ann Rheum Dis 2017 Jan 20;76(1):235-243. Epub 2016 Apr 20.
Dipartimento Biomedico di Medicina Interna e Specialistica, Sezione di Reumatologia, Università degli Studi di Palermo, Palermo, Italy.


Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers.
BMC Med 2016 Dec 1;14(1):194. Epub 2016 Dec 1.
Rheumatology Section, Department of Biotechnological and Applied Clinical Science, School of Medicine, University of L'Aquila, Delta 6 Building, Via dell'Ospedale, 67100, L'Aquila, Italy.


IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone?
Expert Rev Clin Immunol 2016 Aug 12;12(8):849-55. Epub 2016 Apr 12.
a Division of Rheumatology, Department of Biotechnological and Applied Clinical Science , School of Medicine, University of L'Aquila , L'Aquila , Italy.


Perivascular Cells in Diffuse Cutaneous Systemic Sclerosis Overexpress Activated ADAM12 and Are Involved in Myofibroblast Transdifferentiation and Development of Fibrosis.
J Rheumatol 2016 Jul 1;43(7):1340-9. Epub 2016 Jun 1.
From the Department of Applied Clinical Sciences and Biotechnology, Rheumatology Unit, School of Medicine, and the Department of Applied Clinical Sciences and Biotechnology, General Pathology Unit, University of L'Aquila, L'Aquila; Dipartimento Biomedico di Medicina Interna e Specialistica, Sezione di Reumatologia, Università degli Studi di Palermo, Palermo, Italy.P. Cipriani, MD, PhD, Department of Applied Clinical Sciences and Biotechnology, Rheumatology Unit, School of Medicine, University of L'Aquila; P. Di Benedetto, PhD, Department of Applied Clinical Sciences and Biotechnology, Rheumatology Unit, School of Medicine, University of L'Aquila; P. Ruscitti, MD, Department of Applied Clinical Sciences and Biotechnology, Rheumatology Unit, School of Medicine, University of L'Aquila; V. Liakouli, MD, PhD, Department of Applied Clinical Sciences and Biotechnology, Rheumatology Unit, School of Medicine, University of L'Aquila; O. Berardicurti, MD, Department of Applied Clinical Sciences and Biotechnology, Rheumatology Unit, School of Medicine, University of L'Aquila; F. Carubbi, MD, Department of Applied Clinical Sciences and Biotechnology, Rheumatology Unit, School of Medicine, University of L'Aquila; F. Ciccia, MD, PhD, Dipartimento Biomedico di Medicina Interna e Specialistica, Sezione di Reumatologia, Università degli Studi di Palermo; G. Guggino, MD, Dipartimento Biomedico di Medicina Interna e Specialistica, Sezione di Reumatologia, Università degli Studi di Palermo; F. Zazzeroni, PhD, Department of Applied Clinical Sciences and Biotechnology, General Pathology Unit, University of L'Aquila; E. Alesse, MD, PhD, Department of Applied Clinical Sciences and Biotechnology, General Pathology Unit, University of L'Aquila; G. Triolo, MD, PhD, Dipartimento Biomedico di Medicina Interna e Specialistica, Sezione di Reumatologia, Università degli Studi di Palermo; R. Giacomelli, MD, PhD, Department of Applied Clinical Sciences and Biotechnology, Rheumatology Unit, School


Invariant NKT cells are expanded in peripheral blood but are undetectable in salivary glands of patients with primary Sjögren's syndrome.
Clin Exp Rheumatol 2016 Jan-Feb;34(1):25-31. Epub 2015 Dec 1.
Dipartimento Biomedico di Medicina Interna e Specialistica, Sezione di Reumatologia, Università di Palermo, Italy.







Activated IL-22 pathway occurs in the muscle tissues of patients with polymyositis or dermatomyositis and is correlated with disease activity.
Rheumatology (Oxford) 2014 Jul 5;53(7):1307-12. Epub 2014 Mar 5.
Dipartimento Biomedico di Medicina Interna e Specialistiche, Sezione di Reumatologia, Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello, Sezione di Anatomia Patologica, Dipartimento di Biopatologia e Biotecnologie Mediche e Forensi and Dipartimento di Biomedicina Sperimentale e Neuroscienze Cliniche, Università di Palermo, Palermo, Italy.

Rituximab modulates IL-17 expression in the salivary glands of patients with primary Sjögren's syndrome.
Rheumatology (Oxford) 2014 Jul 6;53(7):1313-20. Epub 2014 Mar 6.
Dipartimento Biomedico di Medicina Interna e Specialistiche, Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello, Sezione di Anatomia Patologica, Dipartimento di Biopatologia e Biotecnologie Mediche e Forensi, Università di Palermo, Palermo and Dipartimento di Medicina Interna e Salute pubblica, Sezione di Reumatologia, Università di L'Aquila, L'Aquila, Italy.

Targeting IL-6 signalling in early rheumatoid arthritis is followed by Th1 and Th17 suppression and Th2 expansion.
Clin Exp Rheumatol 2014 Jan-Feb;32(1):77-81. Epub 2014 Jan 14.
Dipartimento Biomedico di Medicina Interna e Specialistica, Sezione di Reumatologia, Università degli studi di Palermo, Italy.

Macrophage phenotype in the subclinical gut inflammation of patients with ankylosing spondylitis.
Rheumatology (Oxford) 2014 Jan 29;53(1):104-13. Epub 2013 Sep 29.
Division of Rheumatology, Department of Internal Medicine, Piazza delle Cliniche 2, 90127 Palermo, Italy.



Potential involvement of IL-22 and IL-22-producing cells in the inflamed salivary glands of patients with Sjogren's syndrome.
Ann Rheum Dis 2012 Feb 6;71(2):295-301. Epub 2011 Oct 6.
Dipartimento Biomedico di Medicina Interna e Specialistiche, Sezione di Reumatologia, Università di Palermo, Italy.


Over-expression of paneth cell-derived anti-microbial peptides in the gut of patients with ankylosing spondylitis and subclinical intestinal inflammation.
Rheumatology (Oxford) 2010 Nov 5;49(11):2076-83. Epub 2010 Aug 5.
Dipartimento Biomedico di Medicina Interna e Specialistica, Divisione di Reumatologia, Università di Palermo, Palermo, Italy.

A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis.
Rheumatol Int 2010 Sep 23;30(11):1437-40. Epub 2009 Oct 23.
Division of Rheumatology, Department of Internal Medicine, University of Palermo, Piazza delle Cliniche 2, 90127, Palermo, Italy.




OF